Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke

Journal of Interventional Cardiac Electrophysiology

Volumn 33, Issue 1, 2012, Pages 69-75

  Viles Gonzalez, Juan F ^a   Reddy, Vivek Y ^a,b   Petru, Jan ^b   Mraz, Tomas ^b   Grossova, Zuzana ^b   Kralovec, Stepan ^b   Neuzil, Petr ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

Atrial fibrillation; Left atrial appendage; Occlusion device; PLAATO; Stroke; Watchman

Indexed keywords

CLOPIDOGREL; WARFARIN;

AGED; ARTICLE; BLOOD FLOW; BRAIN ISCHEMIA; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEART ATRIUM APPENDAGE; HEART LEFT ATRIUM; HUMAN; LUNG EMBOLISM; MALE; PERCUTANEOUS LEFT ATRIAL APPENDAGE TRANSCATHETER OCCLUSION DEVICE; PRIORITY JOURNAL; SCORING SYSTEM; STROKE; TRANSIENT ISCHEMIC ATTACK; ECHOGRAPHY; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; MIDDLE AGED; PROSTHESES AND ORTHOSES; RADIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PROSTHESES AND IMPLANTS; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861695878     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-011-9613-x     Document Type: Article

References (23)

1. Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., et al. (2006). Secular trends in incidence of atrial fibrillation in Olmsted county, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation, 114, 119-125. (Pubitemid 44420743)
2. Connolly, S., Pogue, J., Hart, R., Pfeffer, M., Hohnloser, S., Chrolavicius, S., et al. (2006). Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (active w): A randomised controlled trial. Lancet, 367, 1903-1912.
3. Levine, M. N., Raskob, G., Landefeld, S., & Kearon, C. (2001). Hemorrhagic complications of anticoagulant treatment. Chest, 119, 108S-121S. (Pubitemid 32154197)
4. Hart, R. G., Halperin, J. L., Pearce, L. A., Anderson, D. C., Kronmal, R. A., McBride, R., et al. (2003). Lessons from the stroke prevention in atrial fibrillation trials. Annals of Internal Medicine, 138, 831-838. (Pubitemid 38124645)
5. Wysowski, D. K., Nourjah, P., & Swartz, L. (2007). Bleeding complications with warfarin use: A prevalent adverse effect resulting in regulatory action. Archives of Internal Medicine, 167, 1414-1419. (Pubitemid 47052441)
6. Stoddard, M. F., Dawkins, P. R., Prince, C. R., & Longaker, R. A. (1995). Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation. American Heart Journal, 129, 1204-1215.
7. Madden, J. L. (1949). Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli. Journal of the American Medical Association, 140, 769-772.
8. Holmes, D. R., Reddy, V. Y., Turi, Z. G., Doshi, S. K., Sievert, H., Buchbinder, M., et al. (2009). Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. Lancet, 374, 534-542.
9. Nakai, T., Lesh, M. D., Gerstenfeld, E. P., Virmani, R., Jones, R., & Lee, R. J. (2002). Percutaneous left atrial appendage occlusion (plaato) for preventing cardioembolism: First experience in canine model. Circulation, 105, 2217-2222. (Pubitemid 34517168)
10. Ostermayer, S. H., Reisman, M., Kramer, P. H., Matthews, R. V., Gray, W. A., Block, P. C., et al. (2005). Percutaneous left atrial appendage transcatheter occlusion (plaato system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials. Journal of the American College of Cardiology, 46, 9-14. (Pubitemid 40905122)
11. Kerut, E. K. (2008). Anatomy of the left atrial appendage. Echocardiography, 25, 669-673. (Pubitemid 351861986)
12. Su, P., McCarthy, K. P., & Ho, S. Y. (2008). Occluding the left atrial appendage: Anatomical considerations. Heart, 94, 1166-1170.
13. Schwartzman, D., Katz, W. E., Smith, A. J., & Anderson, W. D. (2007). Malpositioning of a left atrial appendage occlusion device? A case with implications for percutaneous transcatheter left atrial appendage occlusion device therapy. Heart Rhythm, 4, 648-650. (Pubitemid 46630367)
14. Katz, E. S., Tsiamtsiouris, T., Applebaum, R. M., Schwartzbard, A., Tunick, P. A., & Kronzon, I. (2000). Surgical left atrial appendage ligation is frequently incomplete: A transesophageal echocardiograhic study. Journal of the American College of Cardiology, 36, 468-471. (Pubitemid 30624009)
15. Garcia-Fernandez, M. A., Perez-David, E., Quiles, J., Peralta, J., Garcia-Rojas, I., Bermejo, J., et al. (2003). Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: A transesophageal echocardiographic study. Journal of the American College of Cardiology, 42, 1253-1258. (Pubitemid 37188352)
16. Block, P. C., Burstein, S., Casale, P. N., Kramer, P. H., Teirstein, P., Williams, D. O., et al. (2009). Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the plaato (percutaneous left atrial appendage transcatheter occlusion) study. JACC. Cardiovascular Interventions, 2, 594-600.
17. Mahaffey KW R-Ai. Rivaroxaban once-daily oral direct factor xa inhibition compared with vitamin k antagonism for the prevention of stroke and embolism trial in atrial fibrillation. American Heart Association. 2010.
18. El-Chami, M. F., Grow, P., Eilen, D., Lerakis, S., & Block, P. C. (2007). Clinical outcomes three years after plaato implantation. Catheterization and Cardiovascular Interventions, 69, 704-707. (Pubitemid 46581261)
19. Bayard, Y. L., Omran, H., Neuzil, P., Thuesen, L., Pichler, M., Rowland, E., et al. (2010). Plaato (percutaneous left atrial appendage transcatheter occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: Results from the european plaato study. EuroIntervention, 6, 220-226.
20. Blackshear, J. L., & Odell, J. A. (1996). Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. The Annals of Thoracic Surgery, 61, 755-759. (Pubitemid 26060923)
21. Blackshear, J. L., Zabalgoitia, M., Pennock, G., Fenster, P., Strauss, R., Halperin, J., et al. (1999). Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. Spaf tee investigators. Stroke prevention and atrial fibrillation. Transesophageal echocardiography. The American Journal of Cardiology, 83, 453-455. A459.
22. Odell, J. A., Blackshear, J. L., Davies, E., Byrne, W. J., Kollmorgen, C. F., Edwards, W. D., et al. (1996). Thoracoscopic obliteration of the left atrial appendage: Potential for stroke reduction? The Annals of Thoracic Surgery, 61, 565-569. (Pubitemid 26060882)
23. Kanderian, A. S., Gillinov, A. M., Pettersson, G. B., Blackstone, E., & Klein, A. L. (2008). Success of surgical left atrial appendage closure: Assessment by transesophageal echocardiography. Journal of the American College of Cardiology, 52, 924-929.